Cystadane
NDC 52276-400, betaine, powder, for solution, from Recordati Rare Diseases.
- Product NDC
- 52276-400
- Status
- Listed
- Labeler
- Recordati Rare Diseases
- Dosage form
- POWDER, FOR SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020576
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/52276-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BETAINE1 g/g
Pharmacologic classes
Methylating Activity [MoA]; Methylating Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 52276-400-01 | 52276040001 | 180 g in 1 BOTTLE (52276-400-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/31a684d0-cd98-4e46-b43a-ccbd17c41559
Use it
Look up 52276-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/52276-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 52276-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.